Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Liver tumor characterization--review of the literature.

Dietrich CF, Maddalena ME, Cui XW, Schreiber-Dietrich D, Ignee A.

Ultraschall Med. 2012 Jul;33 Suppl 1:S3-10. doi: 10.1055/s-0032-1312897. Epub 2012 Jun 21. Review.

PMID:
22723026
2.

Liver tumor characterization--comments and illustrations regarding guidelines.

Dietrich CF.

Ultraschall Med. 2012 Jul;33 Suppl 1:S22-30. doi: 10.1055/s-0032-1312892. Epub 2012 Jun 21. Review.

PMID:
22723025
3.

Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of hepatocellular and cholangiocellular carcinoma, comments on the AASLD guidelines.

Dietrich CF, Cui XW, Boozari B, Hocke M, Ignee A.

Ultraschall Med. 2012 Jul;33 Suppl 1:S57-66. doi: 10.1055/s-0032-1312903. Epub 2012 Jun 21.

PMID:
22723030
4.

Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.

Wildner D, Pfeifer L, Goertz RS, Bernatik T, Sturm J, Neurath MF, Strobel D.

Ultraschall Med. 2014 Dec;35(6):522-7. doi: 10.1055/s-0034-1385170. Epub 2014 Sep 9.

PMID:
25202903
5.

Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound.

Wang ZL, Tang J, Weskott HP, Li JL, Wang W, Luo YK, An LC, Xu JH.

J Gastroenterol Hepatol. 2008 Oct;23(10):1511-9. doi: 10.1111/j.1440-1746.2008.05435.x. Epub 2008 Aug 17.

PMID:
18713302
6.

Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry.

Heide R, Strobel D, Bernatik T, Goertz RS.

Ultraschall Med. 2010 Aug;31(4):405-9. doi: 10.1055/s-0029-1245565. Epub 2010 Jul 22.

PMID:
20652853
7.

CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.

Wildner D, Bernatik T, Greis C, Seitz K, Neurath MF, Strobel D.

Ultraschall Med. 2015 Apr;36(2):132-9. doi: 10.1055/s-0034-1399147. Epub 2015 Mar 26.

PMID:
25812115
8.

[Liver tumor as incidental ultrasound finding].

Görtz RS, Strobel D.

MMW Fortschr Med. 2010 Jan 21;152(3):41-3. Review. German. No abstract available.

PMID:
20333967
9.

Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).

Strobel D, Seitz K, Blank W, Schuler A, Dietrich CF, von Herbay A, Friedrich-Rust M, Bernatik T.

Ultraschall Med. 2009 Aug;30(4):376-82. doi: 10.1055/s-0028-1109672. Epub 2009 Aug 17.

PMID:
19688669
10.

Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.

Bohle W, Clemens PU, Heubach T, Zoller WG.

Ultraschall Med. 2012 Dec;33(7):E191-E195. doi: 10.1055/s-0031-1282029. Epub 2011 Dec 22.

PMID:
22194045
11.

[Characterization of hepatic tumors with contrast-enhanced ultrasound and digital grey-scale analysis].

Lemke AJ, Chopra SS, Hengst SA, Brinkmann MJ, Steinmüller T, Felix R.

Rofo. 2004 Nov;176(11):1607-16. German.

PMID:
15497079
12.

Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.

Kong WT, Wang WP, Huang BJ, Ding H, Mao F.

J Gastroenterol Hepatol. 2014 Mar;29(3):576-80. doi: 10.1111/jgh.12394.

PMID:
24118042
13.

Characterization of liver lesions by real-time contrast-enhanced ultrasonography.

Celli N, Gaiani S, Piscaglia F, Zironi G, Camaggi V, Leoni S, Righini R, Bolondi L.

Eur J Gastroenterol Hepatol. 2007 Jan;19(1):3-14.

PMID:
17206071
14.

Characterization of focal liver lesions using contrast enhanced ultrasound as a first line method: a large monocentric experience.

Sporea I, Martie A, Bota S, Sirli R, Popescu A, Dănila M.

J Gastrointestin Liver Dis. 2014 Mar;23(1):57-63.

15.

Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.

Bernatik T, Seitz K, Blank W, Schuler A, Dietrich CF, Strobel D.

Ultraschall Med. 2010 Dec;31(6):577-81. doi: 10.1055/s-0029-1245649. Epub 2010 Aug 25.

PMID:
20740399
16.

Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.

Vilana R, Forner A, Bianchi L, García-Criado A, Rimola J, de Lope CR, Reig M, Ayuso C, Brú C, Bruix J.

Hepatology. 2010 Jun;51(6):2020-9. doi: 10.1002/hep.23600.

PMID:
20512990
17.

[Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: diagnostic efficacy and economical issues from a French multicentric study].

Tranquart F, Correas JM, Ladam Marcus V, Manzoni P, Vilgrain V, Aube C, Elmaleh A, Chami L, Claudon M, Cuilleron M, Diris B, Garibaldi F, Lucidarme O, Marion D, Beziat C, Rode A, Tasu JP, Trillaud H, Bleuzen A, Le Gouge A, Giraudeau B, Rusch E.

J Radiol. 2009 Jan;90(1 Pt 2):109-22. French.

18.

Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT--a comparative study.

Loyer EM, Chin H, DuBrow RA, David CL, Eftekhari F, Charnsangavej C.

Radiology. 1999 Sep;212(3):866-75.

PMID:
10478259
19.

Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.

Bertolotto M, Dalla Palma L, Quaia E, Locatelli M.

Eur Radiol. 2000;10(9):1369-76.

PMID:
10997422
20.

CEUS and HCC: are the 2008 EFSUMB guidelines still valid or has their wash-out already started?

Giorgio A, Calisti G, Giorgio V.

Ultraschall Med. 2011 Jun;32(3):315-6. doi: 10.1055/s-0031-1273350. Epub 2011 Jun 10. No abstract available.

PMID:
21667409

Supplemental Content

Support Center